Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Plasma Exchange vs Standard Therapy in Severe Alcoholic Hepatitis
NCT06355726Recruiting
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Apr 2024
- Primary completion
- Feb 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoint: Liver transplant free survival at 180 days. Started Apr 2024; status: recruiting.
Beyond the preview
Go deeper on NCT06355726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06355726.